Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€36.60

€36.60

-1.080%
-0.4
-1.080%
€60.00
 
18:41 / Tradegate WKN: A2GS5D / Name: Dermapharm Holding / Stock / Holding Companies / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:

Description Dermapharm Holding

Dermapharm Holding SE is a German-based pharmaceutical company that operates in the development, production, and marketing of branded skin care and pharmaceutical products. The company's portfolio includes a range of product categories such as dermatological drugs, dietary supplements, women's health, and others. It is headquartered in Grünwald, Germany, and has subsidiaries and production facilities in several countries worldwide, including Germany, Austria, Poland, and Spain.

Dermapharm Holding SE is listed on the Frankfurt Stock Exchange and has a market capitalization of around €1.7 billion. The company is known for its strong focus on research and development, and it invests heavily in innovations that address unmet medical needs. In recent years, Dermapharm Holding SE has experienced significant growth and expansion both organically and through acquisitions, and it has a solid financial position with a positive cash flow and low debt levels.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Dermapharm Holding SE is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Dermapharm Holding

sharewise wants to provide you with the best news and tools for Dermapharm Holding, so we directly link to the best financial data sources.

News

EQS-News: Dermapharm Holding SE performs in line with projections in Q1 2025, confirms full-year guidance
EQS-News: Dermapharm Holding SE performs in line with projections in Q1 2025, confirms full-year guidance
EQS-News: Dermapharm Holding SE performs in line with projections in Q1 2025, confirms full-year guidance
EQS-News: Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance
EQS-News: Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance
EQS-News: Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance
EQS-News: Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA
EQS-News: Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA
EQS-News: Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA